Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
63.76
-0.27 (-0.42%)
Apr 29, 2026, 3:00 PM CST
SHA:688513 Market Cap
SHA:688513 has a market cap or net worth of 11.16 billion as of April 29, 2026. Its market cap has increased by 97.07% in one year.
Market Cap
11.16B
Enterprise Value
9.72B
Revenue
1.35B
Ranking
n/a
PE Ratio
40.51
Stock Price
63.76
Market Cap Chart
Since September 2, 2020, SHA:688513's market cap has increased from 8.97B to 11.16B, an increase of 24.41%. That is a compound annual growth rate of 3.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Vaccine | 11.18B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 10.93B |
| Chongqing Genrix Biopharmaceutical | 11.53B |
| Chengdu Olymvax Biopharmaceuticals | 11.55B |
| HitGen | 10.49B |
| Pacific Shuanglin Bio-pharmacy | 11.93B |
| Vcanbio Cell & Gene Engineering Corp., | 12.35B |
| Jiangxi Fushine Pharmaceutical | 9.85B |